SCHEMBL7640918

SCHEMBL7640918

COC(=O)CCCn1ccc(O)cc1=O

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KAT2B Q92831 4/20 0.48
TNF P01375 7/20 0.47
MIF P14174 1/20 0.40
ALDH1A1 P00352 2/20 0.40
KDM4E B2RXH2 1/20 0.40
GLA P06280 1/20 0.40
GAA P10253 1/20 0.40
TSHR P16473 1/20 0.40
ALOX5 P09917 1/20 0.40
EPHX2 P34913 1/20 0.40
DUT P33316 1/20 0.39
DRD2 P14416 1/20 0.38
DRD3 P35462 1/20 0.38
MAPK13 O15264 1/20 0.38
MAPK12 P53778 1/20 0.38
MAPK11 Q15759 1/20 0.38
MAPK14 Q16539 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7636901 0.79 MAPK14 (0.60) MAPK14
SCHEMBL30910238 0.76 GPR84 (0.47) KAT2BALDH1A1KDM4EGAATSHR
SCHEMBL5005631 0.76 ACACB (0.44) ALDH1A1GAATSHRDRD2DRD3
SCHEMBL1998981 0.73 DRD2 (0.41) TNFDRD2DRD3MAPK14
SCHEMBL2881295 0.72 CYP1A2 (0.54) ALDH1A1KDM4E
SCHEMBL31584793 0.71 TNF (0.47) KAT2BTNFALDH1A1TSHRDUT
SCHEMBL22610155 0.71 CDK4 (0.60) TNFALDH1A1TSHR
SCHEMBL1038378 0.70 GRM2 (0.41) ALDH1A1TSHR
SCHEMBL18913971 0.70 GSK3A (0.46) TNFALDH1A1KDM4ETSHR
SCHEMBL24110048 0.70 TNF (0.39) KAT2BTNFALDH1A1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6465495-B1 INHIBITING DISEASE STATES ASSOCIATED WITH PROTEIN PROTEIN INTERACTION MEDIATED BY A SH2 OR SH3 DOMAIN OR A TYROSINE PHOSPHATASE SUCH AS ALLERGIES, ASTHMA, ANEMIA, AUTOIMMUNE DISEASES, CANCER, INFLAMMATORY DISEASES, OSTEOPOROSIS OSI PHARMACEUTICALS, INC. 2002-10-15 US disclosed